The Use of Leukapheresis to Support HIV Pathogenesis Studies
NCT01161199 is an observational study sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies HIV. The registry lists an enrollment of 100 participants at 1 site in 1 country. The registry lists a start date of 26 Oct 2010 and a primary completion date of 31 Jul 2033. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01161199 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | University of California, San Francisco |
| Enrollment | 100 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | HIV |
| Start | 26 Oct 2010 |
| Primary completion | 31 Jul 2033 |
| Study completion | 31 Jul 2033 |
| Last update posted | 1 May 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01161199
Each answer restates registry values shown on this page.
What is NCT01161199?
NCT01161199 is an observational study sponsored by University of California, San Francisco. It studies HIV.
Is NCT01161199 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT01161199?
The registry names Steven Deeks, MD (principal investigator, University of California, San Francisco) as the overall official.
Where does NCT01161199 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT01161199 expected to complete?
The registry lists a primary completion date of 31 Jul 2033 and a study completion date of 31 Jul 2033. The sponsor last updated the record on 1 May 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.